Research.Patient.info

Recurrent head and neck cancer research hub

2 indexed studies · 1 currently recruiting

recruiting
The development of a Patient Decision Aid (PDA) and Patient Concerns Inventory (PCI) for people diagnosed with recurrent head and neck cancer (HNC)
This study aims to create tools for people with recurring head and neck cancer. These tools will help patients understand treatment choices and share their worries with their healthcare team, making sure their voices are heard during difficult decisions.
United Kingdom · England
recruitingPHASE2, PHASE3
A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1
This study is for people with a type of head and neck cancer linked to HPV16. It compares a new treatment (BNT113 plus pembrolizumab) with pembrolizumab alone to see if the new combination is safe and works better.
United States · Argentina · Australia